<DOC>
	<DOCNO>NCT01201434</DOCNO>
	<brief_summary>Patients Cystic Fibrosis multiple pulmonary infection repeat antibiotic treatment . These factor take together high sputum viscosity slow motility gastrointestinal tract-may change pathogenicity consistency intestinal pathogen . Part pulmonary infection CF patient due intestinal pathogen . A pilot study perform researcher use probiotic CF patient show decrease rate pulmonary infection . Therefore , plan double-blind placebo-controlled trial examine effect probiotic pulmonary infection , sputum bacteria sputum inflammatory marker CF patient .</brief_summary>
	<brief_title>Effect Probiotics Sputum Inflammation Pulmonary Infections Patients With Cystic Fibrosis</brief_title>
	<detailed_description>Patients Cystic Fibrosis multiple pulmonary infection repeat antibiotic treatment . These factor take together high sputum viscosity slow motility gastrointestinal tract-may change pathogenicity consistency intestinal pathogen . Part pulmonary infection CF patient due intestinal pathogen . A pilot study perform researcher use probiotic CF patient show decrease rate pulmonary infection . Therefore , plan double-blind placebo-controlled trial examine effect probiotic pulmonary infection , sputum bacteria sputum inflammatory marker CF patient . The study cross-over study probiotic placebo arm .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>cystic fibrosis mild moderate least 3 pulmonary exacerbation require antibiotic per year Pseudomonas aeruginosa sputum able produce sputum severe pulmonary disease le 3 pulmonary exacerbation per year unable produce sputum</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>probiotic</keyword>
	<keyword>pulmonary</keyword>
	<keyword>infection</keyword>
</DOC>